Prof. Aiwu Ruth He

Go Back

GI Medical Oncologist

  • Columbia University Medical Center
  • location United States

Aiwu Ruth He, MD, PhD is a Professor of Medicine at Columbia University Medical Center. She earned her MD from the Xiangya School of Medicine at Central South University and her PhD in Biochemistry from East Carolina University’s Brody School of Medicine. Dr He completed her postdoctoral training at the National Institutes of Health under the mentorship of Dr Simeon Taylor, followed by an internal medicine residency at the Brody School of Medicine and a Hematology/Oncology fellowship at Georgetown University Hospital.

 

Dr He is a recognized leader in liver cancer research and patient care, with a primary focus on developing innovative therapeutics for hepatocellular carcinoma (HCC) and biliary tract cancer (BTC). 

 

She is deeply committed to a programmatic, multidisciplinary approach to clinical practice, ensuring optimal outcomes for her patients across the continuum of care.

 

Outside of her clinical duties, Dr He serves as the Director of Hepatobiliary Cancers in the Department of Medicine, Division of Hematology and Oncology, as well as the Director of Liver Transplant Oncology at the Center for Liver Disease and Transplantation. In these roles, she oversees clinical research on hepatobiliary cancers.

 

For a list of publications, please visit:

https://pubmed.ncbi.nlm.nih.gov/?term=he%2C+AR+or+He%2C+aiwu

Prof. Aiwu Ruth He has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AstraZeneca, BMS, Boston Scientific, Eisai, Genentech and Merck.

Programmes developed by Prof. Aiwu Ruth He

micro-learning Micro learning

Module

3

of 3

module
Oncology 
The expanding role of immunotherapy in HCC

Module 3: Combining locoregional and systemic treatments in intermediate HCC

Experts
Prof. Aiwu Ruth He, Prof. Beau Toskich
Endorsed by
Global Liver Institute ELPA DiCE
Blue Faery
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Apr 2025

AstraZeneca has provided a sponsorship grant towards this independent programme.
micro-learning Micro learning

Module

2

of 3

module
Oncology 
The Use of Immunotherapy in HCC

Module 2: In-depth Subgroup Analyses and Challenges

Experts
Prof. Dr Peter R. Galle, Prof. Aiwu Ruth He
Endorsed by
AASLD
Digestive Cancers Europe
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Jun 2023

Educational programme supported by an Independent Educational Grant from AstraZeneca
micro-learning Micro learning

Module

1

of 3

module
Oncology 
The Use of Immunotherapy in HCC

Module 1: Efficacy and Safety

Experts
Prof. Dr Peter R. Galle, Prof. Aiwu Ruth He
Endorsed by
AASLD
Digestive Cancers Europe
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Apr 2023

Educational programme supported by an Independent Educational Grant from AstraZeneca
Oncology 
HCC treatment algorithm with systemic therapy based on the recently updated HCC guidelines

Experts
Prof. Aiwu Ruth He, Assoc. Prof. Matthias Pinter
  • download Downloadable
    Resources
  • clock 30 MIN
  • calendar Nov 2021

Educational programme supported by an Independent Educational Grant from Bayer
publication Publication
Oncology 
HCC CONNECT review paper published in Liver Cancer

Experts
Dr Mohamed Bouattour, Assoc. Prof. Neil Mehta, Prof. Aiwu Ruth He, Dr Emil I Cohen, Assoc. Prof. Jean-Charles Nault
  • download Downloadable
    Resources
  • clock MIN
  • calendar Sep 2021

Educational programme supported by an Independent Educational Grant from Bayer

Episode

2

of 2

episode
Oncology 
HCC CONNECT Update from ILCA 2018

Epìsode 2

Experts
Prof. Aiwu Ruth He
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2021

Educational programme supported by an Independent Educational Grant from Bayer